Improving Ischemic Outcomes in ACS: Lessons and Case Discussions from the Experts is organized by C3-Interventional Academy.

Release Date: Mar 01, 2020
Expiration Date: Apr 30, 2020

Target Audience:
This activity is intended for attendees of C3 Annual Meeting and other clinicians: interventional cardiologists, cardiologists, vascular surgeons, cardiothoracic surgeons, primary care physicians, technologists and nurses who manage thrombotic risks across diverse patient populations.

Ciné-Med outlined this abiding material for a maximum of 2 AMA PRA Category 1Credit(s)™. Physicians can claim the credit commensurate based on the extent of their participation in the activity

Educational Objectives:
At the conclusion of the session, participants will be able to,
• Review the newest guidelines for antiplatelet therapy in ACS
• Explain the impact of oral antiplatelet therapy on Cardiovascular Mortality in ACS
• Explain the latest efficacy and safety data of antiplatelet therapies for patients undergoing PCI
• Examine the advantages and challenges of managing longer-term antiplatelet therapy for reduction of cardiovascular risk

Additional details will be posted as soon as information is available.

Intended Audience

Cardiology, Vascular Surgery

Activity Payment Details

Activity Fee : NA

Rate this CME (Min 1 - Max 5)

Fee and expenses:
CME credits:
Program contents:
Write Your Review

Reviews Given by Professionals

No Reviews available. Be the first to write a review.

Privacy Policy

Read eMedEvents Privacy Policy


C3-Interventional Academy

View Organizer Details


773-714-0705, ext. 205